Reducing Diagnosis Time for Patients

NI company Cirdan have announced a new contract with the Australian Centre for the Prevention of Cervical Cancer.

Associate Professor Dave Hawkes Director Molecular Microbiology at ACPCC, commented that “the introduction of the new Cirdan LIMS will allow us to continue to build our versatility whilst maintaining our high quality approach to reporting patients pathology results”.

Cirdan is a leading provider of pathology informatics and imaging solutions that support and speed up patient diagnosis. Headquartered in NI, with offices in Canada and Australia, Cirdan is recognised as one of the leading suppliers of laboratory information systems (LIS) worldwide. Their products include ULTRA, a LIS that supports and streamlines the operations of a clinical laboratory, and the CoreLite and Solas x-ray specimen cabinets which expedite breast cancer diagnosis.

Find out more at cirdan.com and read the full story at https://www.healthservicesdaily.com.au/cervical-cancer-nfp-partners-with-cirdan-to-future-proof-its-labs/15213

Related News

Hosted by the Health Innovation and Research Alliance NI (HIRANI), Health Tech Spring is a two-day conference taking place in…

We are delighted to announce The Academy of Medical Sciences’ Cross-Sector Programme to promote health innovation continues to grow, with…

The University of Oxford’s Centre for Research Equity (CfRE) this week launched a historic partnership to advance health equity in…

Disrupting into the next chapter

Health Tech Spring 2024 provides a stage for thought leaders and influential speakers in healthcare.

Learn how we helped 100 top brands gain success